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The regioselective attack on microsomal phospholipid (PL) polar heads (PH) and fatty acyl chains (FC) demonstrated in vitro has been exploited for
the selective quantitation in vivo of the biochemical damages produced by the oxidation and reduction products of CHCI3 metabolism. Five hours
after CHC13 injection (60 mg/kg body weight, ip) to control Sprague-Dawley rats, most of the label covalently bound in the liver was associated to PH,
indicating a predominant production of COC12. The levels of radioactivity bound to both PL moieties increased proportionally when 180 mg/kg body
weight 14CHC13 was administered. Buthionine sulfoximine (BSO) pretreatment resulted in a further increase of binding either to PH or FC. The
pretreatment of rats with phenobarbital (PB) reduced the PH/FC binding ratio to 3.4, still indicating the predominance of the oxidative metabolism,
but giving some indication of the simultaneous presence of CHCI3 reduction.When reduced glutathione (GSH) was depleted by BSO in PB-induced
animals prior to 14CHCI3 administration, only the level of radioactivity associated with oxidative intermediates was increased six times.The present 3 ~~~~~~~~~~~~~~~~~~14 results confirmed that GSH is able to exert an efficient protection mainly toward CHCI3 oxidation intermediates. Furthermore, they indicate that in
the liver of the Sprague-Dawley rat the major pathway of CHCI3 biotransformation is its oxidation and that pretreatment of rats with a GSH-depleting
agent (such as BSO) is more relevant than PB induction in enhancing the biochemical damages produced by CHCI3 -Environ Health Perspect
102(Suppl 9):45-47 (1994)
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Introduction
It is now widely accepted that chloroform
can be both oxidized to phosgene (1,2) and
reductively biotransformed in vitro and in
vivo to dichloromethyl radical (3,4). Either
type of reactive intermediates can react in
vitro with cellular structures to form cova-
lent adducts (5-7). Although the produc-
tion of COCd2 has been associated with
chloroform-induced acute toxicity (8-10),
also the reductively produced metabolites
can be involved in CHCl3 toxicity. In fact,
CHC13 can stimulate lipid peroxidation in
PB-pretreated Sprague-Dawley microsomal
phospholipids rats (11-13), which are
more susceptible to chloroform-induced
hepatoxicity than control rats (14).
It has been shown in vitro that PL are
the major site ofCHC13-induced damage,
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in experimental conditions resembling the
physiological status of the liver (6,7).
Moreover, our recent results, obtained in
vitro by means of chemical transmethyla-
tion or ofenzymatic hydrolysis with phos-
pholipase C (15), indicated that the
different reactive intermediates (namely,
COCd2 and .CHCl2) show a typical regio-
selectivity in the attack to PL. Indeed,
while COCd2 binds preferentially to PL
polar heads, PL fatty acyl chains are the
main target for dichloromethyl radicals.
This feature has been exploited in this
preliminary study for the selective in vivo
quantitation of the binding due to each
type of intermediates to assess if the two
metabolic pathways are simultaneously
active in the liver ofSprague-Dawley rats.
Furthermore, we investigated different
effects of PB, a well-known enhancer of
CHCl3 toxicity (16,17), and of BSO,
which is able to deplete GSH in vivo (18),
on the two metabolic pathways ofCHCl3.
Materials and Methods
Chemicals
(14C)-Chloroform (=3.0 mCi/mmole,
radiochemical purity 99%) was obtained
from New England Nuclear (Boston, MA).
Unlabeled chloroform (IR purity) was from
Merck (Darmstad, Germany).
BSO was supplied by Sigma (St. Louis,
MO), sodium-PB by Fluka (Buchs,
Switzerland) and Tanax by Hoechst A.G.
(Frankfurt am Main, Germany). Liquid
scintillation cocktails Aqualuma and
Lipoluma were purchased from Lumac
System A.G. (Basel, Switzerland). All other
reagents used were of the highest purity
commercially available.
Aninals
Male Sprague-Dawley rats (180-200 g)
were from Nossan (Italy). Theywere main-
tained on a 12-hr light cycle and provided
food and water ad libitum for 1 week
before the start ofthe experiments.
When required, animals were pre-
treated with 0.1% (w/v) PB sodium salt in
drinking water for 1 week; BSO, dissolved
in distilled H20 was injected (2 nmoles/kg
body weight, ip) 2 hr before 14CHCI3
treatment.
Animals were treated with 14CHCI in 3
corn oil (60-180 mg/kg bodyweight, ip) 5
hr before sacrifice, obtained by injecting
(ip) a lethal dose ofTanax. 14CHCI3-spe-
cific radioactivity (0.15-0.49 mCi/mmole)
was adjusted in order to inject each animal
with the same amount of radioactivity per
kg bodyweight
During treatment, rats were maintained
in all glass metabolism cages (Metabowls
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Figure 1. Dose dependence of the in vivo binding of
14CHC13 metabolites to liver microsomal phospholipids.
14CHC13 (specific radioactivity 0. 15-0. 49 mCi/mmole)
was injected ip to control male Sprague-Dawley rats.
Results are expressed as nmoles 14C bound to microso-
mal PL/g liver. Values represent means and standard
deviations (SD) calculated on microsomal preparation
coming from at least two treated animals.Levels of p
forthe comparison between data of polar heads (upper
value) and fatty acyl chain (lower value) are reported.
Values of radioactivity to PH and FC differ significantly
(p<0001) in all cases. Abbreviations: FC, fatty acyl
chains; PH, polar heads.
MK III, Jencons Scientific Ltd.), provided
with water and with an air flow of 500
ml/min.
Covalent Binding of14C&
Chloroform Metabolites
Microsomal preparations from rat livers
were obtained as previously described (5).
Microsomal lipid extracts were obtained
from an aliquot of microsomal suspension
(250 pl) corresponding to about 0.5 g of
wet liver tissue, according to the method of
Folch (19), and repeatedly dried to elimi-
nate the residues of free substrate. Then
covalent binding of '4CHC13 metabolites
to PL polar heads (PH) and fatty acyl
chains (FC) was determined after the acid-
catalyzed transmethylation ofliver micro-
somal PL, as described in detail by De
Biasi et al. (15). Briefly, the lipid extract-
was dissolved in 1 ml of anhydrous
methanol:benzene:H2SO4 (75:25:1) and
vigorously shaken for 1 hr at 700C. The
reaction mixture was cooled in an ice bath,
then 2 ml petroleum ether (BP 40°-70°)
and 1 ml 0.26 M K2HPO4 were added.
After 10 min vigorous shaking, the mixture
was centrifuged (3,000 rpm, 10 min). The
lower aqueous layer, containing the free
hydrophylic PH, was transferred into a
plastic vial containing 17 ml Aqualuma.
The upper organic phase, containing the
PL fatty acid methyl esters, was washed
twice and then a 2-ml aliquot was trans-
ferred into a plastic vial containing 10 ml
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Figure 2. Effect of BS0 pretreatment on in vivoregios-
elective binding of 14CHC13 metabolites to liver micro-
somal phospholipids.The dose of 14CHC13 injected ip to
male Sprague-Dawley rats was 180 mg/kg body
weight (specific radioactivity 0.15 mCi/mmole). Results
are expressed as nmoles 14C bound to microsomal
PL/g liver. Values represent means and standard devi-
ations (SD) calculated on microsomal preparation com-
ing from at least two treated animals. Levels of p for
the comparison between data of polar heads (upper
values) and fatty acyl chain (lower value) are reported.
Values of radioactivity to PH and FC differ significantly
(p<0,001) in all cases. Abbreviations: FC, fatty acyl
chains; PH, polar heads.
Lipoluma. Data were compared by means
ofthe Student's t-test.
Results
After the ip administration of 60 mg/kg
body weight 14CHCI3 to control male
Sprague Dawley rats, most of the label
covalently bound in the liver was associated
to PL hydrophilic PH (Figure 1). Indeed
the binding was about 6-fold higher than
the label bound to FC.
This amount of radioactivity bound
either to PH or FC increased proportion-
ally when a 3-fold higher dose (180 mg/kg
bodyweight) was administered (Figure 1).
When control rats were pretreated with
BSO prior to 14CHCI3 administration, the
effect of GSH depletion on covalent bind-
ing could be observed. The total amount of
radioactivity was 7-fold higher (Figure 2).
The binding associated to both microsomal
PL moieties resulted similarly affected (no
significant changes in the ratio PH/FC-
associated label).
The pretreatment of rats with PB
nearly doubled the total PL covalent bind-
ing due to 14CHC13 metabolites (Figure 3).
The radioactivity bound to FC increased
slightly but significantly more than that
one associated to PH.
When BSO was administered to PB-
induced animals prior to 14CHC13 injec-
tion, the level of total radioactivity bound
to PL was 6.5 fold increased with respect
to that measured in PB-induced rat liver
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Figure 3. Effects of PB- and combined PB Plus BS0-
pretreatment on in vivo regioselectivity binding of
14CHC13 metabolites to liver microsomal phospho-
lipids. The dose of 14CHC13 injected ip to male
Sprague-Dawley rats was 60 mg/kg body weight (spe-
cific radioactivity -0.45 mCi/mmole).Results are
expressed as nmoles 14C bound to microsomal PL/g
liver. Values represent means and standard deviations
(SD) calculated on microsomal preparation coming
from at least two treated animals.Levels of p for the
comparison between data of polar heads (upper val-
ues) and fatty acyl chain (lower value) are reported.
Values of radioactivity to PH and FC differ significantly
(p<0.001) in all cases. Abbreviations: FC, fatty acyl
chains; PH, polar heads.
(Figure 3). The variation was due only to
the increase of radioactivity associated to
PH, since the level ofcovalent binding to
FC was not significantly changed.
Discussion
Injection of a single subtoxic dose of
14CHCl3 to variously pretreated Sprague-
Dawley rats resulted in a predominant
binding of the 14C label to the PH of
hepatic microsomal PL, indicating that
COC12 is the major product of CHCl3
bioactivation. Indeed, the ratio of radioac-
tivity associated with PH with respect to
that of FC (PH/FC) was about six and
remained almost constant at the two
dosage levels tested of 14CHCI3. The
observed binding to FC may not be attrib-
uted with certainty to the radicals derived
from CHCI3 reduction, since the regiose-
lectivity of binding to PL shown by the
two CHCl3 metabolites is not absolute
(15).
This finding is in line with previous in
vitro results (7,15), suggesting that in
hepatic microsomes from control Sprague-
Dawley rats in experimental conditions
mimicking the physiologic oxygenation of
the liver, reductive metabolism is not sig-
nificantly expressed or requires very low
P02 values. Pretreatment of Sprague-
Dawley rats with PB prior to 14CHCl3
caused the binding to FC to increase sig-
nificantly more than the binding to PH.
The PH/FC binding ratio decreased to 3.4.
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These data indicate the predominance of
CHC13 oxidative metabolism, and suggest
that some contribution by the reductive
pathway is also present.
The marked increase of total PL bind-
ing (together with the increase of PH/FC
binding ratio up to 21.8) in liver micro-
somes of rats pretreated with BSO indi-
cated that GSH exerts in vivo a highly
efficient scavenging action toward the
CHC13 intermediate produced through the
oxidative pathway. The greater susceptibil-
ity to CHC13-induced hepatotoxicity
observed in GSH-depleted rats (16) may
be associated mainly to a decreased protec-
tion against COC12, the major product of
CHCI3 oxidation (1,2,8).
These preliminary results suggest that
in the liver ofeither control or PB-induced
Sprague-Dawley rats the predominant bio-
transformation pathway of CHC13 is its
oxidation and that the damages exerted by
CHC13 on the microsomal PL are potenti-
ated by GSH-depleting agents such as
BSO, more than PB-like inducers of
CHC13 metabolism.
REFERENCES
1. Mansuy D, Beaune P, Cresteil TH, Lange M, Leroux JP. Evi-
dence for phosgene formation during liver microsomal oxida-
tion of chloroform. Biochem Biophys Res Commun
79:513-517 (1977).
2. Pohl RL, Bhooshan B, Whittaker NF, Krishna G. Phosgene: a
metabolite of chloroform. Biochem Biophys Res Commun
79:684-691 (1977).
3. Tomasi A, Albano E, Biasi F, Slater TF, Vannini V, Dianzani
MU. Activation ofchloroform and related trihalomethanes to
free radical intermediates in isolated hepatocytes and in the rat
in vivo as detected by the ESR-spin trapping technique. Chem
Biol Interact 55:303-316 (1985).
4. Antonelli A, Di Domenico A, Testai E, Vittozzi L, Volpi F.
Reactive intermediates produced in the reductive metabolism of
CHC13. In: Abstracts, ISSX 2nd European Symposium on
Foreign Compound Metabolism. Frankfurt, 1987;38.
5. Testai E, Vittozzi L. Biochemical alterations elicited in rat liver
microsomes by oxidation and reduction products ofchloroform
metabolism. Chem Biol Interact 59:157-171, (1986).
6. Testai E, Di Marzio S, Vittozzi L. Multiple activation ofchlo-
roform in hepatic microsomes from uninduced B6C3F1 mice.
ToxicolAppl Pharmacol 104:496-503 (1990).
7. Testai E, Gemma S, Vittozzi L. Bioactivation ofchloroform in
hepatic microsomes from rodent strains susceptible or resistant
to CHC13 carcinogenicity. Toxicol Appl Pharmacol
114:197-203 (1992).
8. Pohl RL, Martin JL George JW. Mechanism ofmetabolic acti-
vation of chloroform by rat liver microsomes. Biochem
Pharmacol 29:3271-3276 (1980).
9. Pohl LR, Krishna G. Deuterium isotope effect in bioactivation
and hepatotoxicity of chloroform. Life Sci 23:1067-1072
(1978).
10. Brown BR Jr., Sipes IG, Sagalyn AM. Mechanisms of acute
hepatic toxicity, chloroform, halothane and glutathione.
Anesthesiology 41:554-561 (1974).
11. Klaasseh, CD, Plaa GL. Comparison of the biochemical alter-
ations elicited in livers from rats treated with carbon tetrachlo-
ride, chloroform, 1,1,2-trichloroethane and 1,1,l-trichloroethane.
Biochem Pharmacol 18:2019-2027 (1969).
12. Brown BRJr. Hepatic microsomal lipoperoxidation and inhala-
tion anesthetics: a biochemical and morphologic study in the
rat. Anesthesiology 36:458-465 (1972).
13. Masuda Y, Yano I, Murano T. Comparative studies on the
hepatotoxic actions of chloroform and related halogeno-
methanes in normal and phenobarbital-pretreated animals. J
Pharm Dyn 3:53-64 (1980).
14. Docks EL, Krishna G. The role ofglutathione in chloroform-
induced hepatotoxicity. Exp Mol Pathol 24:13-22 (1976).
15. DeBiasi A, Sbraccia M, Keizer J, Testai E, Vittozzi L. The
regioselective binding of CHCI3 metabolites to microsomal
phospholipids. Chem Biol Interact (in press).
16. Stevens JL, Anders MW. Effect ofcysteine, diethylmaleate, and
phenobarbital treatments on the hepatotoxicity of (lH)- and
(2H)-chloroform. Chem Biol Interact 37:207-217 (1981).
17. Branchflower RV, Schulick RD, George JW, Pohl LR.
Comparison ofthe effects ofmethyl-N-butyl ketone and phe-
nobarbital on rat liver cytochromes P-450 and the metabolism
of chloroform to phosgene. Toxicol Appl Pharmacol 71:414-
421 (1983).
18. White RD, Norton R, Bus JS. The effect ofbuthionine sulfox-
imine, an inhibitor of glutathione synthesis, on hepatic drug
metabolism in the male mouse. Toxicol Lett 23:25-32 (1984).
19. Folch J, Lees M, Sloane-Stanley GM. A simple method for the
isolation and purification oftotal lipids from animal tissues. J
Biol Chem 226:497 (1957).
Volume 102, Supplement9, November 1994 47